ADC Series
ADCs have the characteristics of both small molecule and macromolecular drugs, bringing unique challenges to ADC DMPK research. The ADC series includes DMPK challenges, strategies for ADC payload release and metabolism, bioanalytical strategies, application of radiolabeling techniques in ADC PK studies, and drug conjugate linkers and their effects on drug properties, etc.
-
Novel Drug Modalities
-
Therapeutic Areas
Connect with us
-
Strategies and Methods for Studying ADC Payload Release and Metabolism
ArticlesJul 13,2023Learn More
-
The Strategies and Methods for In-Vitro ADME Characterization of ADCs
WebinarsAug 18,2023Learn More -
Preclinical Drug Development Testing for Antibody-Drug Conjugate (ADC)
BrochuresMay 04,2023Learn More -
The Many DMPK Challenges of Cancer Treatment ADCs
BlogsMay 11,2023Learn More -
A New Method to Improve Identification of the Payload-Containing Catabolites of ADCs
BlogsAug 10,2023Learn More -
Comprehensive Bioanalysis of ADCs in DMPK Studies
ArticlesAug 10,2023Learn More -
Integrated Bioanalytical Platform Accelerates ADC IND Filing
PostersMay 12,2023Learn More -
Drug Conjugate Linkers and Their Effects on Drug Properties
ArticlesAug 10,2023Learn More -
Application of Radiolabeling Techniques in ADC PK Studies
ArticlesJul 26,2023Learn More -
Antibody-Drug Conjugate (ADC) Bioanalysis Strategies Based on LC-MS
ArticlesJul 20,2023Learn More -
Webinar Q&A | The Strategies and Methods for In Vitro ADME Characterization of ADCs
BlogsAug 23,2023Learn More -
In Vitro/Vivo Characterization of ADC Drugs by Immunocapture and High-resolution Mass Spectrometry
PostersMay 19,2023Learn More
Load More
Still have a question?
Talk to an expert
Related Service
Stay Connected
Keep up with the latest news and insights.
